These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38081413)

  • 21. Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus-A case-control study.
    Garg D; Soundappan K; Agarwal R; Mukherjee S; Kumar M; Dhooria S; Sehgal IS; Prasad KT; Ramachandran R; Patil S; Aggarwal AN; Rudramurthy SM; Chakrabarti A; Muthu V
    Mycoses; 2023 Sep; 66(9):787-794. PubMed ID: 37191090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
    Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
    Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID associated pulmonary mucormycosis: Outcomes of surgical therapy.
    Pulle MV; Bishnoi S; Asaf BB; Puri HV; Deshwal V; Kumar A
    Asian Cardiovasc Thorac Ann; 2023 Feb; 31(2):133-141. PubMed ID: 36426415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.
    Khatri A; Chang KM; Berlinrut I; Wallach F
    J Mycol Med; 2021 Jun; 31(2):101125. PubMed ID: 33857916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
    Menia R; Raychaudhuri S; Agarwal C; Taneja J
    Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
    Kumar S; Kumar H; Mali M; Meena BL
    Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
    Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
    Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic.
    Mehta RM; Bansal S; Kalpakkam H
    Lung India; 2022; 39(2):187-190. PubMed ID: 35259803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.
    Özbek L; Topçu U; Manay M; Esen BH; Bektas SN; Aydın S; Özdemir B; Khostelidi SN; Klimko N; Cornely O; Zakhour J; Kanj SS; Seidel D; Hoenigl M; Ergönül Ö
    Clin Microbiol Infect; 2023 Jun; 29(6):722-731. PubMed ID: 36921716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
    Meshram HS; Kute VB; Chauhan S; Dave R; Patel H; Banerjee S; Desai S; Kumar D; Navadiya V; Mishra V
    Int Urol Nephrol; 2022 Jul; 54(7):1693-1703. PubMed ID: 34792722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India.
    Chavan RP; Ingole SM; Nazir HA; Desai WV; Kanchewad GS
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3201-3210. PubMed ID: 35122509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of real-time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis.
    Seo H; Kim JY; Son HJ; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Kim SH
    Mycoses; 2021 Dec; 64(12):1554-1562. PubMed ID: 34013523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 associated mucormycosis: A Descriptive Multisite Study from India.
    Gupta R; Kesavadev J; Krishnan G; Agarwal S; Saboo B; Shah M; Mittal A; Durani S; Luthra A; Singhal A; Rasheed M; Rao GVS; Tripathi V; Jha A; Ghosh A; Mohan V; Singh AK; Phatak S; Panicker J; Bhadada SK; Joshi S; Pal R; Mithal A; Vikram N; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102322. PubMed ID: 34717135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19-associated Mucormycosis: A clinico-epidemiological study.
    Chakravarty J; Gupta MK; Tilak R; Kumar R; Maurya RP; Kumar N; Aggarwal SK; S S; Sharma NK; Dhiman NK; Chaubey M; Singh V; Verma A; Banerjee T; Agrawal NK; Prasad RS
    J Diabetes Complications; 2022 Sep; 36(9):108284. PubMed ID: 35987108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.